Pacira BioSciences, Inc. - 8-K Filing

Pacira BioSciences completes merger with Viatris Inc. subsidiary for approximately $1.69 billion in total consideration. (Items: 1.01 Entry into a Material Definitive Agreement, 1.02 Termination of Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 2.04 Triggering Events that Accelerate or Increase a Direct Financial Obligations or an Obligation under an Off-Balance Sheet Arrangement)

SEC EDGAR ·

Tickers: $PCRX

Read the full article at SEC EDGAR

Part of the story Twist Bioscience Corp - 10-K Filing (2 articles)

More Regulatory news